Abstract:Cortex Lycii, as a kind of traditional Chinese medicines, have shown prospects in the prevention of diabetes and its complications. However, there is comparatively little information regarding the characterization of potentially hypoglycemic compounds derived from Cortex Lycii. In this study, we performed a global non-selective investigation of α-glucosidase inhibitors in Cortex Lycii based on a bioactivity-labeling high-resolution mass spectrometry–metabolomics method. Samples of Cortex Lycii were collected from different Chinese provinces and their ethyl acetate extracts were analyzed using an in vitro α-glucosidase inhibition assay for bioactivity-labeling. The ethyl acetate extracts were also subjected to liquid chromatography-mass spectrometry analysis and multivariate data analysis was subsequently conducted to identify correlations between the bioactivity measured from the enzyme-involved test and the profiles obtained based on high-resolution mass spectrometry. The variables contributing significantly to the separation of the more-active from the less-active samples were considered to indicate the potential target ions of active compounds. MS/MS fragment patterns and nuclear magnetic resonance analyses were used to identify the potential target ions. The developed platform mentioned above facilitated rapid identification of four α-glucosidase inhibitors, namely, N-p-trans-coumaroyltyramine (1), N-trans-caffeoyl-tyramine (2), (9R,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3a), and (9S,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3b) from Cortex Lycii. The α-glucosidase inhibitory activities of compounds 3a and 3b with IC50 values of 1.0413±0.0551 and 1.0423±0.0049 mM, respectively, are reported here for the first time. Enzyme kinetics revealed that both 3a and 3b were non-competitive inhibitors of α-glucosidase, with Ki values of 2.20 and 2.24 mM, respectively. In short, the presented work identified compounds 3a and 3b as potential α-glucosidase inhibitors with higher inhibitory activity and a different mode of inhibition compared to the standard α-glucosidase inhibitor, acarbose. The integrated approach adopted in this study can be extended as a normalized procedure to rapidly identify active compounds, even from complex extracts, and can readily be adapted for the study of other natural products.

Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells.

A New Flavan-3-ol Lactone and Other Constituents from Euonymus Alatus with Inhibitory Activities on Α-Glucosidase and Differentiation of 3T3-L1 Cells.

The Anti-Diabetic Effect of Eight Lagerstroemia Speciosa Leaf Extracts Based on the Contents of Ellagitannins and Ellagic Acid Derivatives.

Screening, Characterization of Trace Α-Glucosidase Inhibitors from the Root of Pueraria Lobata and Evaluation of Their Hypoglycemic Activity

Compounds From Angelica Keiskei With Nqo1 Induction, Dpph Center Dot Scavenging And Alpha-Glucosidase Inhibitory Activities

Triterpene Acids Isolated From Lagerstroemia Speciosa Leaves As Alpha-Glucosidase Inhibitors

Triterpene acids isolated from<i>Lagerstroemia speciosa</i>leaves as<i>α</i>-glucosidase inhibitors

Schisphenlignans A-E: Five New Dibenzocyclooctadiene Lignans From Schisandra Sphenanthera

Bioactive ellagitannins and phenylpropanoid glycosides from the seed of Torreya grandis

Six new lignans from the leaves and stems of Schisandra sphenanthera.

Anti-α-Glucosidase Activities and Bioactive Components of Tibetan Hull-Less Barley Bran Extracts

Four new diastereoisomeric neolignan glycosides from the root bark of Lycium chinense Miller. And their α -glucosidase inhibitory activity

Identification of Α-Glucosidase Inhibitors from Cortex Lycii Based on a Bioactivity-Labeling High-Resolution Mass Spectrometry–metabolomics Investigation

Identification, potency evaluation, and mechanism clarification of α-glucosidase inhibitors from tender leaves of Lithocarpus polystachyus Rehd

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Triterpenoids from Cyclocarya Paliurus That Enhance Glucose Uptake in 3T3-L1 Adipocytes

Aromatic Constituents from the Stems of Astragalus membranaceus (Fisch.) Bge. var. Mongholicus (Bge.) Hsiao

In Vitro and in Silico Analysis of PTP1B Inhibitors from Cleistocalyx operculatus Leaves and Their Effect on Glucose Uptake

Exploration of potential antidiabetic and antioxidant components from the branches of Mitragyna diversifolia and possible mechanism

Lanostane Triterpenoids with Glucose-Uptake-Stimulatory Activity from Peels of the Cultivated Edible Mushroom Wolfiporia cocos

[Bioactivity Guided Isolation of Alpha-Glucosidase Inhibitor from Whole Herbs of Crossostephium Chinense].